Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in Pennsylvania 2026: $69 a month, plus yearly membership

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to Pennsylvania from four of our partner programs. The lowest of the programs we track is $69 a month at Collective, plus a yearly membership, read on November 11, 2026.

Medicaid for weight loss
Not covered
Partner programs that ship here
Eden, Collective, SnagRx and CoreAge Rx
Adults with obesity
33.5% (CDC, 2025)

Compounded tirzepatide prices in Pennsylvania

ProgramMonthly priceCheckedProgram's site
Eden logoEden$129 a monthNovember 11, 2026Check price →
Collective logoCollective$69 a month, plus yearly membershipNovember 11, 2026Check price →
SnagRx logoSnagRx$149 a month, or $119 a month paid 12 months up frontNovember 11, 2026
CoreAge Rx logoCoreAge Rx$129 a monthNovember 11, 2026

Eden, Collective, SnagRx and CoreAge Rx pay GLP Chart when you buy through our links.

What a year of compounded tirzepatide costs in Pennsylvania

  • Eden ships to Pennsylvania at $1,548 for 12 months.
  • Collective ships to Pennsylvania at $1,027 for 12 months with its membership.
  • SnagRx ships to Pennsylvania at $1,788 for 12 months, or $1,428 if Pennsylvania buyers pay 12 months up front.
  • CoreAge Rx ships to Pennsylvania at $1,548 for 12 months.

For compounded semaglutide, Pennsylvania buyers pay from $59 a month at Collective, plus a yearly membership, against $69 for compounded tirzepatide in Pennsylvania.

Does Pennsylvania Medicaid cover Zepbound?

Pennsylvania Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. Pennsylvania Medicaid plans include UPMC for You, Highmark Wholecare, Geisinger Health Plan and AmeriHealth Caritas Pennsylvania. No Pennsylvania Medicaid plan pays for compounded tirzepatide, so it is a cash purchase. Pennsylvania Medicaid GLP-1 rules.

Obesity in Pennsylvania

33.5% of adults in Pennsylvania had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. That puts Pennsylvania 0.0 points above the national rate, about 3 in 10 Pennsylvania adults.

More for Pennsylvania

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.